Complete Filing Data
SciSparc Ltd. reported Cash And Cash Equivalents of $1.54 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SciSparc Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $1.7M | $1.6M | $2.8M | $2.0M | $649.0K | $1.6M | $2.7M | $1.9M | $740.0K | -$240.0K |
| Profit Loss From Operating Activities | -$7.3M | -$6.8M | -$8.3M | -$5.8M | -$3.3M | -$4.1M | -$7.2M | -$5.8M | -$2.0M | $2.6M |
| Profit Loss | -$7.5M | -$5.9M | -$2.6M | -$5.8M | -$3.5M | -$4.7M | -$8.9M | -$6.2M | -$2.0M | $2.6M |
| General And Administrative Expense | $4.5M | $3.8M | $5.4M | $3.8M | $1.9M | $2.5M | $4.4M | $3.8M | $1.3M | -$1.4M |
| Adjustments For Reconcile Profit Loss | $2.2M | $829.0K | -$4.6M | $85.0K | $574.0K | $2.1M | $422.0K | $1.4M | $299.0K | $1.1M |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | $136.0K | -$833.0K | -$703.0K | $643.0K | -$1.3M | -$2.1M | $1.4M | $272.0K | $234.0K | $129.0K |
| Profit Loss Attributable To Owners Of Parent | -$6.3M | -$5.1M | -$2.6M | -$5.8M | $3.5M | $4.7M | $8.5M | $6.2M | $2.0M | $2.5M |
| Profit Loss Before Tax | -$7.5M | -$5.9M | -$2.6M | -$5.8M | -$3.5M | -$9.0M | -$6.2M | -$2.0M | $2.6M | |
| Gross Profit | $506.0K | $2.2M | $1.0M | |||||||
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -$429.0K | -$210.0K | -$109.0K | -$742.0K | $49.0K | |||||
| Profit Loss Attributable To Noncontrolling Interests | -$1.2M | -$761.0K | $53.0K | -$108.0K | $426.0K | $14.0K | $76.0K | |||
| Income Tax Expense Continuing Operations | -$14.0K | $22.0K | $14.0K | -$60.0K | ||||||
| Cost Of Sales | $800.0K | $683.0K | $322.0K | |||||||
| Sales And Marketing Expense | $1.5M | $2.5M | $1.1M | |||||||
| Comprehensive Income | -$2.6M | -$5.8M | -$3.5M | -$4.7M | $9.2M | $5.8M | $1.8M | $2.6M | ||
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | $1.3M | $1.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $1.5M | $2.1M | $3.6M | $6.9M | $1.9M | $870.0K | $1.5M | $9.2M | $676.0K | $1.6M | $157.0K |
| Cash Flows From Used In Financing Activities | $6.2M | $8.5M | $11.7M | $10.1M | $5.4M | $2.8M | $1.5M | $13.2M | $565.0K | $2.7M | |
| Cash Flows From Used In Investing Activities | -$1.6M | -$4.1M | -$7.1M | -$70.0K | $24.0K | $1.3M | -$2.1M | -$53.0K | -$5.0K | -$1.0K | |
| Cash Flows From Used In Operating Activities | -$5.1M | -$5.9M | -$7.9M | -$5.1M | -$4.3M | -$4.7M | -$7.1M | -$4.6M | -$1.5M | -$1.4M | |
| Adjustments For Decrease Increase In Trade Account Receivable | $12.0K | $55.0K | -$77.0K | $170.0K | -$519.0K | $329.0K | -$99.0K | -$143.0K | -$110.0K | -$46.0K | |
| Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents | $45.0K | -$5.0K | -$15.0K | -$35.0K | $24.0K | -$1.0K | -$10.0K | -$11.0K | |||
| Retained Earnings | -$75.0M | -$68.7M | -$63.6M | -$61.0M | -$55.2M | -$51.7M | -$46.9M | -$38.4M | -$32.1M | ||
| Adjustments For Increase Decrease In Trade Account Payable | $25.0K | -$397.0K | $353.0K | -$752.0K | -$840.0K | $177.0K | $349.0K | $233.0K | $154.0K | ||
| Trade And Other Payables To Trade Suppliers | $816.0K | $802.0K | $1.2M | $1.2M | $556.0K | $864.0K | $1.6M | $1.0M | $590.0K | ||
| Trade And Other Current Payables | $205.0K | $185.0K | $193.0K | $154.0K | $34.0K | $108.0K | $844.0K | $160.0K | $82.0K | ||
| Property Plant And Equipment | $59.0K | $108.0K | $57.0K | $92.0K | $11.0K | $175.0K | $2.1M | $50.0K | $11.0K | ||
| Other Equity Interest | $810.0K | $810.0K | $559.0K | $559.0K | $559.0K | $261.0K | $261.0K | $261.0K | $261.0K | ||
| Noncurrent Assets | $2.8M | $4.7M | $6.1M | $92.0K | $11.0K | $199.0K | $2.1M | $69.0K | $441.0K | ||
| Equity And Liabilities | $10.3M | $11.2M | $10.6M | $9.9M | $2.6M | $1.2M | $4.6M | $9.6M | $1.2M | ||
| Current Liabilities | $1.4M | $1.6M | $4.2M | $1.8M | $1.1M | $1.0M | $4.5M | $1.2M | $672.0K | ||
| Current Assets | $7.5M | $6.4M | $4.5M | $9.8M | $2.6M | $955.0K | $2.4M | $9.5M | $804.0K | ||
| Assets | $10.3M | $11.2M | $10.6M | $9.9M | $2.6M | $1.2M | $4.6M | $9.6M | $1.2M | ||
| Current Restricted Cash And Cash Equivalents | $20.0K | $65.0K | $60.0K | $45.0K | $10.0K | $10.0K | $10.0K | $24.0K | $11.0K | ||
| Adjustments For Increase Decrease In Trade And Other Payables | $20.0K | -$8.0K | $39.0K | $120.0K | |||||||
| Current Trade Receivables | $10.0K | $22.0K | $77.0K | $2.9M | $594.0K | $75.0K | $404.0K | $278.0K | $117.0K | ||
| Equity Attributable To Owners Of Parent | $8.2M | $7.6M | $6.4M | $14.0K | $185.0K | $8.4M | |||||
| Other Current Receivables | $1.1M | $540.0K | $131.0K | $2.9M | |||||||
| Intangible Assets Other Than Goodwill | $1.5M | $3.2M | $4.7M | ||||||||
| Warrant Liability | $5.2M | $5.2M | $5.2M | ||||||||
| Adjustments For Losses From Remeasurement Of Investment In Financial Assets | $305.0K | $1.0M | $770.0K | ||||||||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $8.0K | $35.0K | $315.0K | $1.0K | $17.0K | $44.0K | $4.0K | $2.0K | |||
| Current Lease Liabilities | $37.0K | $52.0K | $27.0K | $45.0K | |||||||
| Purchase Of Investments Other Than Investments Accounted For Using Equity Method | $600.0K | $400.0K | $700.0K | ||||||||
| Other Noncurrent Financial Assets | $354.0K | $659.0K | $730.0K | ||||||||
| Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments | $3.0M | -$3.0M | -$700.0K | ||||||||
| Noncurrent Lease Liabilities | $9.0K | $24.0K | $18.0K | $94.0K | |||||||
| Current Warrant Liability | $191.0K | $2.7M | |||||||||
| Adjustments For Decrease Increase In Other Operating Receivables | -$409.0K | $3.0K | $170.0K | ||||||||
| Rightofuse Asset Recognized With Corresponding Lease Liability | $75.0K | $102.0K | $78.0K | ||||||||
| Adjustments For Increase Decrease In Other Operating Payables | $39.0K | $120.0K | -$75.0K | -$736.0K | $649.0K | $66.0K | $111.0K | $21.0K | |||
| Investments In Associates | $781.0K | $591.0K | |||||||||
| Investment Accounted For Using Equity Method | $952.0K | $781.0K | $591.0K | ||||||||
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | $210.0K | $109.0K | |||||||||
| Adjustments For Decrease Increase In Trade And Other Receivables | -$535.0K | -$409.0K | $3.0K | ||||||||
| Adjustments For Share Of Losses Of Company Accounted For At Equity Net | $429.0K | $210.0K | $109.0K | ||||||||
| Shortterm Deposits Classified As Cash Equivalents | $3.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | -$536.0K | -$1.5M | -$3.3M | $4.9M | $1.1M | -$615.0K | -$7.7M | $8.5M | -$897.0K | $1.4M |
| Payments Of Lease Liabilities Classified As Financing Activities | $54.0K | $47.0K | $70.0K | $19.0K | ||||||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$1.5M | -$3.3M | $4.9M | -$321.0K | $503.0K | $25.0K | -$5.0K | |||
| Proceeds From Issue Of Share Capital And Warrantsnet Of Issuance Expenses | -$5.6M | -$9.0M | -$7.7M | |||||||
| Proceeds From Issuing Shares | 6.3M | 5.6M | 9.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Basic Earnings Loss Per Share | $1.28 | $14.43 | $14.82 | $73.58 | $0.10 | $0.64 | $1.20 |
| Diluted Earnings Loss Per Share | $1.28 | $14.43 | $14.82 | $73.58 | $0.11 | $0.64 | $1.20 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Finance Costs | $353.0K | $1.1M | $2.0M | $21.0K | $872.0K | $676.0K | $121.0K | $491.0K | $8.0K | -$9.0K |
| Adjustments For Finance Income Cost | $897.0K | $2.2M | $6.6M | -$9.0K | $476.0K | -$156.0K | $748.0K | -$525.0K | -$2.0K | $67.0K |
| Adjustments For Depreciation And Amortisation Expense | $482.0K | $538.0K | $187.0K | $33.0K | $164.0K | $179.0K | $147.0K | $5.0K | $4.0K | $3.0K |
| Adjustments For Sharebased Payments | $569.0K | $196.0K | $897.0K | $43.0K | $91.0K | $553.0K | $604.0K | $862.0K | $327.0K | $1.1M |
| Finance Income | $612.0K | $2.2M | $7.8M | $630.0K | $305.0K | $828.0K | $1.0K | $1.0K | -$5.0K | |
| Reserve Of Exchange Differences On Translation | $497.0K | $497.0K | $497.0K | $497.0K | $497.0K | $497.0K | $497.0K | $782.0K | $321.0K | |
| Reserve Of Sharebased Payments | $5.7M | $5.3M | $5.2M | $4.3M | $4.3M | $4.9M | $4.4M | $5.3M | $4.4M | |
| Share Premium | $70.9M | $64.5M | $58.6M | $39.3M | $38.1M | $36.6M | $26.6M | |||
| Adjustments For Decrease Increase In Inventories | $629.0K | -$74.0K | -$668.0K | |||||||
| Inventories | $113.0K | $742.0K | $668.0K | |||||||
| Share Issue Related Cost | $288.0K | $7.7M | $5.0M | $2.1M | $958.0K | $1.5M | ||||
| Noncontrolling Interests | $785.0K | $2.0M | -$108.0K | |||||||
| Issue Of Share Capital Net Of Issue Expense | $6.3M | $5.6M | $7.7M | |||||||
| Interest Paid Classified As Financing Activities | $8.0K | $7.0K | $8.0K |
Most recent annual filing with the SEC: April 24, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.